What IR teams should plan for in 2H 2026 — conference calendar, NDR strategy, virtual/in-person mix, and the strategic themes shaping investor engagement.
A board-level framework for evaluating IR team performance through corporate access metrics — beyond meeting count, to coverage, conversion, and shareholder base outcomes.
Why healthcare and biotech corporate access works differently — JPM Healthcare Week, KOL meetings, scientific conferences, and the dedicated coverage ecosystem.
A practical corporate access playbook for small-cap IR teams — how to punch above weight with strategic conference selection, targeted NDRs, and platform-driven workflow.
A step-by-step NDR planning guide — city selection, sell-side hosting, meeting density, management time, and post-NDR follow-up. Built for IR teams running 6–14 NDR days
How IR teams use corporate access data — meeting history, fund profiles, peer ownership — to systematically target the funds most likely to become long-term
A 12-month IR engagement calendar built around earnings, conferences, NDRs, and proactive buy-side outreach. How WeConvene helps IR teams plan the year.
How IR teams measure the ROI of corporate access programs in 2026 — engagement metrics, attribution models, and how WeConvene’s analytics platform surfaces actionable program
ESG investor communication in 2026 has matured beyond disclosure compliance. What institutional investors actually want to discuss — and how to structure productive ESG engagement.
How IR teams build investor target lists that maximize acceptance rates in 2026 — ownership data, engagement scoring, peer analysis, and AI-assisted prioritization.
